V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002354 | 330001320 | null | 83 | Palliative (P) | 2015-03-03 | 2015-03-11 | CARBOPLATIN + ETOPOSIDE | N | Y | 330008739 | CARBOPLATIN + ETOPOSIDE |
| 330002355 | 330001321 | 1.64 | 90.2 | Palliative (P) | 2013-07-09 | 2013-07-10 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330008764 | CARBOPLATIN + PACLITAXEL |
| 330002356 | 330001322 | 1.57 | 78 | Palliative (P) | 2014-06-18 | 2014-06-21 | Carboplatin + Etoposide iv&po | 2 | null | 330008772 | CARBOPLATIN + ETOPOSIDE |
| 330002357 | 330001322 | 1.6 | 59 | Palliative (P) | 2015-05-14 | 2015-05-15 | CARBOPLATIN | 2 | null | 330008772 | CARBOPLATIN |
| 330002358 | 330001323 | 0 | 65.5 | Disease modification (D) | 2018-06-26 | 2018-07-16 | Bendamustine+Rituximab (1st Course) | N | N | 330008805 | BENDAMUSTINE + RITUXIMAB |
| 330002359 | 330001323 | 1.8 | 78 | Curative (C) | 2017-11-05 | 2017-11-11 | Carboplatin + Etoposide iv&po | N | N | 330008805 | CARBOPLATIN + ETOPOSIDE |
| 330002360 | 330001323 | 1.7 | 73.9 | null | 2015-05-07 | 2015-05-08 | CNS GCT II Germinoma - Carbo Etop | 2 | N | 330008805 | CARBOPLATIN + ETOPOSIDE |
| 330002361 | 330001323 | 1.68 | 80.9 | null | 2017-06-15 | 2017-06-30 | Rituximab | 02 | N | 330008805 | RITUXIMAB |
| 330002362 | 330001323 | null | 69.4 | Curative (C) | 2017-06-09 | 2017-07-08 | Carboplatin + Etoposide iv&po | 02 | N | 330008805 | CARBOPLATIN + ETOPOSIDE |
| 330002363 | 330001323 | 1.56 | 88.35 | Disease modification (D) | 2017-03-28 | 2017-03-29 | Bendamustine+Rituximab (1st Course) | 02 | N | 330008805 | BENDAMUSTINE + RITUXIMAB |
| 330002364 | 330001324 | 1.8 | 58.5 | Curative (C) | 2017-03-16 | 2017-03-25 | Bendamustine+Rituximab(Sub Courses) | N | N | 330008828 | BENDAMUSTINE + RITUXIMAB |
| 330002365 | 330001325 | 1.59 | 96 | Neo-adjuvant (N) | 2014-11-14 | 2014-11-19 | Cisplatin + Doxorubicin | 2 | null | 330008835 | CISPLATIN + DOXORUBICIN |
| 330002366 | 330006698 | 1.8 | 89.5 | null | 2016-10-06 | 2016-10-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330008841 | CARBOPLATIN + ETOPOSIDE |
| 330002367 | 330009615 | 1.59 | 102.6 | Disease modification (D) | 2013-12-04 | 2013-12-10 | Rituximab | N | N | 330008844 | RITUXIMAB |
| 330002368 | 330009615 | 1.79 | 71.5 | Curative (C) | 2014-02-22 | 2014-02-28 | Rituximab | N | N | 330008844 | RITUXIMAB |
| 330002369 | 330001326 | 1.66 | 98 | Neo-adjuvant (N) | 2015-08-28 | 2015-08-28 | Cisplatin + Doxorubicin | 02 | N | 330008853 | CISPLATIN + DOXORUBICIN |
| 330002370 | 330006699 | 1.78 | 87.2 | null | 2017-04-16 | 2017-04-23 | Carboplatin AUC 6 - 10 | N | N | 330008855 | CARBOPLATIN |
| 330002371 | 330001327 | 1.6 | null | Palliative (P) | 2014-05-24 | 2014-06-18 | Cisplatin + Doxorubicin | N | N | 330008859 | CISPLATIN + DOXORUBICIN |
| 330002372 | 330001328 | 1.56 | 56 | Curative (C) | 2017-05-22 | 2017-05-28 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 330008861 | CARBOPLATIN + PACLITAXEL |
| 330002373 | 330006700 | 1.53 | 44.3 | Palliative (P) | 2016-01-31 | 2016-03-12 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330008865 | CARBOPLATIN + PACLITAXEL |
| 330002374 | 330006700 | 1.64 | 68.6 | Curative (C) | 2014-06-03 | 2014-06-04 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330008865 | LIPOSOMAL DOXORUBICIN |
| 330002375 | 330006700 | 1.7 | 76 | Not known (9) | 2013-05-19 | 2013-05-26 | CNS GCT II Germinoma - Carbo Etop | null | null | 330008865 | CARBOPLATIN + ETOPOSIDE |
| 330002376 | 330001329 | 1.6 | 74.5 | Disease modification (D) | 2017-12-03 | 2017-12-08 | Rituximab | N | N | 330008874 | RITUXIMAB |
| 330002377 | 330001329 | 1.8 | 52.7 | Not known (9) | 2014-02-23 | 2014-02-27 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 330008874 | LIPOSOMAL DOXORUBICIN |
| 330002378 | 330001329 | null | 81 | Palliative (P) | 2015-03-26 | 2015-03-27 | CARBOPLATIN | null | N | 330008874 | CARBOPLATIN |
| 330002379 | 330001329 | 1.78 | 81.5 | Palliative (P) | 2016-01-04 | 2016-01-11 | Carboplatin + Etoposide iv&po | N | N | 330008874 | CARBOPLATIN + ETOPOSIDE |
| 330002380 | 330001330 | 1.68 | 60.85 | Adjuvant (A) | 2013-08-07 | 2013-08-27 | CARBOPLATIN + PACLITAXEL | N | N | 330008886 | CARBOPLATIN + PACLITAXEL |
| 330002381 | 330006702 | 1.55 | 58.9 | Not known (9) | 2014-07-28 | 2014-07-29 | BENDAMUSTINE + RITUXIMAB | 2 | null | 330008887 | BENDAMUSTINE + RITUXIMAB |
| 330002382 | 330006702 | 160 | 57.8 | Neo-adjuvant (N) | 2013-07-13 | 2013-07-18 | Cisplatin + Doxorubicin | N | N | 330008887 | CISPLATIN + DOXORUBICIN |
| 330002383 | 330001331 | 1.84 | 66.4 | Curative (C) | 2015-01-06 | 2015-01-21 | CNS GCT II Germinoma - Carbo Etop | N | N | 330008895 | CARBOPLATIN + ETOPOSIDE |
| 330002384 | 330001332 | 1.7 | 67.1 | Curative (C) | 2014-10-19 | 2014-10-31 | Bendamustine+Rituximab (1st Course) | 02 | N | 330008900 | BENDAMUSTINE + RITUXIMAB |
| 330002385 | 330001333 | 1.7 | 101.8 | Adjuvant (A) | 2016-01-25 | 2016-02-22 | Cisplatin + Doxorubicin | N | N | 330008903 | CISPLATIN + DOXORUBICIN |
| 330002386 | 330001334 | 1.79 | 60.9 | Palliative (P) | 2014-12-03 | 2014-12-03 | Carboplatin + Etoposide iv&po | 2 | Y | 330008905 | CARBOPLATIN + ETOPOSIDE |
| 330002387 | 330001335 | 1.6 | 61 | Disease modification (D) | 2017-11-28 | 2017-12-14 | BENDAMUSTINE + RITUXIMAB | N | N | 330008907 | BENDAMUSTINE + RITUXIMAB |
| 330002388 | 330001335 | 1.7 | 65 | Adjuvant (A) | 2017-12-03 | 2017-12-18 | Cisplatin + Doxorubicin | N | Y | 330008907 | CISPLATIN + DOXORUBICIN |
| 330002389 | 330001335 | 1.86 | null | Palliative (P) | 2017-09-26 | 2017-10-17 | BENDAMUSTINE + RITUXIMAB | N | N | 330008907 | BENDAMUSTINE + RITUXIMAB |
| 330002390 | 330001336 | 1.57 | 81 | null | 2014-05-29 | 2014-06-26 | BENDAMUSTINE + RITUXIMAB | N | Y | 330008927 | BENDAMUSTINE + RITUXIMAB |
| 330002391 | 330001336 | 1.47 | 55.85 | Palliative (P) | null | 2013-10-12 | Carboplatin AUC 2 - 5 | N | N | 330008927 | CARBOPLATIN |
| 330002392 | 330001336 | 1.64 | 52.3 | Disease modification (D) | 2015-07-22 | 2015-07-22 | Liposomal Doxorubicin (20mg/m2) | 02 | null | 330008927 | LIPOSOMAL DOXORUBICIN |
| 330002393 | 330001336 | null | 60 | null | 2018-02-10 | 2018-02-11 | Rituximab | N | N | 330008927 | RITUXIMAB |
| 330002394 | 330001337 | 1.6 | null | Curative (C) | 2018-01-11 | 2018-01-11 | Cisplatin + Doxorubicin | N | N | 330008940 | CISPLATIN + DOXORUBICIN |
| 330002395 | 330001338 | 1.57 | null | null | 2014-06-10 | 2014-06-10 | Carboplatin AUC 2 - 5 | 2 | null | 330008943 | CARBOPLATIN |
| 330002397 | 330001340 | 1.8 | 96.7 | Adjuvant (A) | 2014-02-01 | 2014-02-08 | Cisplatin + Doxorubicin | 02 | N | 330008949 | CISPLATIN + DOXORUBICIN |
| 330002398 | 330001340 | 1.68 | 62.7 | Curative (C) | 2018-05-17 | 2018-05-23 | Rituximab | N | N | 330008949 | RITUXIMAB |
| 330002399 | 330001340 | 1.65 | 91 | Curative (C) | 2015-11-09 | 2015-11-09 | CARBOPLATIN + PACLITAXEL | N | N | 330008949 | CARBOPLATIN + PACLITAXEL |
| 330002400 | 330001340 | 1.77 | 62.5 | Palliative (P) | 2017-08-29 | 2017-08-30 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330008949 | CARBOPLATIN + PACLITAXEL |
| 330002404 | 330001341 | 1.58 | null | Curative (C) | 2015-08-12 | 2015-08-18 | Carboplatin AUC 2 - 5 | 02 | N | 330008968 | CARBOPLATIN |
| 330002405 | 330006706 | 1.78 | 68.6 | Neo-adjuvant (N) | 2013-09-02 | 2013-09-05 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 330008974 | LIPOSOMAL DOXORUBICIN |
| 330002406 | 330001342 | 1.66 | 74.5 | Palliative (P) | 2017-06-08 | 2017-06-15 | Liposomal Doxorubicin (20mg/m2) | N | N | 330008977 | LIPOSOMAL DOXORUBICIN |
| 330002407 | 330001343 | 1.68 | 69.8 | Palliative (P) | 2014-02-11 | 2014-02-25 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330008984 | CARBOPLATIN + PACLITAXEL |